Cancer-associated fibroblasts: from basic science to anticancer therapy

D Yang, J Liu, H Qian, Q Zhuang - Experimental & Molecular Medicine, 2023 - nature.com
Abstract Cancer-associated fibroblasts (CAFs), as a central component of the tumor
microenvironment in primary and metastatic tumors, profoundly influence the behavior of …

Glucose metabolism of TAMs in tumor chemoresistance and metastasis

J Liu, X Cao - Trends in Cell Biology, 2023 - cell.com
Tumor-associated macrophages (TAMs) are critical in promoting tumor progression and
therapeutic resistance. In adapting to metabolic changes in the tumor microenvironment …

Guanine nucleotide exchange factors for Rho GTPases (RhoGEFs) as oncogenic effectors and strategic therapeutic targets in metastatic cancer

RD Cervantes-Villagrana, I García-Jiménez… - Cellular …, 2023 - Elsevier
Metastatic cancer cells dynamically adjust their shape to adhere, invade, migrate, and
expand to generate secondary tumors. Inherent to these processes is the constant assembly …

Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer

M Kundu, R Butti, VK Panda, D Malhotra, S Das… - Molecular Cancer, 2024 - Springer
Breast cancer, the most frequent female malignancy, is often curable when detected at an
early stage. The treatment of metastatic breast cancer is more challenging and may be …

Antibody drug conjugates in breast cancer in China: Highlights, challenges, and prospects

J Li, Z Jiang - Cancer, 2024 - Wiley Online Library
Antibody drug conjugates (ADCs) are novel drugs that exert specific cytotoxicity against
tumor cells. China approved T‐Dxd in May 2023, and their introduction has changed the …

Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers

X Wu, S Huang, W He, M Song - International Immunopharmacology, 2023 - Elsevier
HER2 is an established therapeutic target in breast, gastric, and gastroesophageal junction
carcinomas with HER2 overexpression or genomic alterations. The humanized monoclonal …

Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy …

J Zhu, Q Huang, X Peng, C Luo, Z Liu, D Liu… - Frontiers in …, 2023 - frontiersin.org
Background Previous studies have demonstrated that PANoptosis is strongly correlated with
cancer immunity and progression. This study aimed to develop a PANoptosis-related …

A TGF-β–dominant chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children

X Xiang, Y Hao, C Cheng, H Hu, H Chen, J Tan… - Hepatology, 2024 - journals.lww.com
A TGF-β–dominant chemoresistant phenotype of hepatoblastoma... : Hepatology A TGF-β–dominant
chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children …

Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1‐Mediated Resistant Colorectal Cancer Therapy

G Cui, S Deng, B Zhang, M Wang, Z Lin… - Advanced …, 2024 - Wiley Online Library
The extracellular matrix (ECM) is critical for drug resistance in colorectal cancer (CRC). The
abundant collagen within the ECM significantly influences tumor progression and matrix …

Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and …

S Nersesian, RJ Arseneau, JP Mejia, SN Lee… - Frontiers in …, 2024 - frontiersin.org
Background For patients with high grade serous carcinoma of the ovary (HGSC), survival
rates have remained static for the last half century. Despite the presence of tumor mutations …